Ketamine and other NMDA antagonists: Early clinical trials and possible mechanisms in depression

The APA Council of Research Task Force on Novel Biomarkers and Treatments

Research output: Contribution to journalReview articlepeer-review

319 Scopus citations

Fingerprint

Dive into the research topics of 'Ketamine and other NMDA antagonists: Early clinical trials and possible mechanisms in depression'. Together they form a unique fingerprint.

Medicine & Life Sciences